gip and glp 1 mechanism of action Current Insights, Advantages Challenges Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review GLP-1 Agonists Can Be Heaven
Description
it is a cash-pay compounded model only
Group GLP-1 RA group starts do have their place in increasing prescribing and access to GLP-1 RA therapies for PwD who could benefit potentially most
Yu, M., Wang, K., Liu, H
508511 Additionally, GLP-1 mitigates liver inflammation and fibrosis by inhibiting the NF-B pathway, reducing the release of pro-inflammatory cytokines such as TNF- and IL-6, and thus suppressing inflammatory pathways
Practice Point 4.3.3: GLP-1 RA should not be used in combination with DPP-4 inhibitors
